Skip to main content
48°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by TELA Bio, Inc.
< Previous
1
2
Next >
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio to Take Part in Connecting the Dots
December 05, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
November 16, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 10, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Reports Third Quarter 2023 Financial Results
November 09, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio to Announce Third Quarter 2023 Financial Results
October 26, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
September 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
August 16, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Reports Second Quarter 2023 Financial Results
August 09, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio to Participate in the Jefferies Global Healthcare Conference
May 25, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
May 19, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Reports First Quarter 2023 Financial Results
May 11, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
May 09, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 08, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio to Participate in the JMP Securities Life Sciences Conference
May 02, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio to Announce First Quarter 2023 Financial Results
April 27, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces Pricing of Public Offering of Common Stock
April 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces Proposed Public Offering of Common Stock
April 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023
March 29, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
March 23, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
March 21, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications
March 16, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 24, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques
February 21, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
February 14, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds
January 09, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Tickers
TELA
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.